Skip to main content
. 2015 Nov 28;21(44):12667–12675. doi: 10.3748/wjg.v21.i44.12667

Figure 4.

Figure 4

Comparison of prevalence rate of cytomegalovirus infection in 4 groups, including, ulcerative colitis inactive patients with immunosuppressive drugs, ulcerative colitis inactive patients without immunosuppressive drugs, ulcerative colitis active patients with immunosuppressive drugs, and ulcerative colitis active patients without immunosuppressive drugs. CMV: Cytomegalovirus.